SCHEMBL24767896

SCHEMBL24767896

c1ccc2c(c1)[nH]c1c2c2ccncc2c2oc3ccccc3c12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ GMNN O75496 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ NR3C1 P04150 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ CYP1A1 P04798 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ LCK P06239 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ KIT P10721 1/20 0.51
▸ TOP2A P11388 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19988527 0.90 MAP3K11 (0.52) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL17465511 0.86 MAP3K11 (0.51) ALDH1A1MEN1POLBMAPTRAB9A
SCHEMBL24767921 0.83 KDM4E (0.47) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL18688088 0.80 MAP3K11 (0.49) MEN1POLBMAPTRAB9AKMT2A
SCHEMBL16275794 0.80 MAP3K11 (0.53) ALDH1A1MEN1POLBMAPTRAB9A
SCHEMBL17228831 0.78 MAP3K11 (0.59) KDM4EALDH1A1MEN1POLBMAPT
SCHEMBL29506369 0.78 MAP3K11 (0.59) KDM4EALDH1A1MEN1POLBMAPT
SCHEMBL30883881 0.78 MAP3K11 (0.59) KDM4EALDH1A1MEN1POLBMAPT
SCHEMBL24768761 0.77 GABRA1 (0.49) KDM4ESMN1; SMN2CDK4CCND1MAP3K11
SCHEMBL18086412 0.77 MAP3K11 (0.51) KDM4EALDH1A1MEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220251077-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2022-08-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220251077-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME SLCO4C1, SLCO2A1, SLCO2B1 KDM4E 2549/4885ALDH1A1 404/4885HPGD 2350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback